BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2019
View Archived Issues
To sleep, perchance to clean: Sleep-inducing protein plays role in immunity
Read More
Stretching taxes CRISPR's abilities
Read More
Typhus vaccination broadly alters immune response
Read More
Sacituzumab govitecan demonstrates clinical activity in patients with metastatic urothelial cancer
Read More
Novel SIRT7 inhibitor demonstrates promising safety and efficacy in preclinical cancer models
Read More
Nektar Therapeutics presents preliminary data from phase Ib/II REVEAL study
Read More
Janssen reports phase I/II data for cetrelimab in patients with advanced cancers
Read More
Preliminary results from phase II study of lifileucel in metastatic melanoma
Read More
Adagene announces platform evaluation with Celgene
Read More
Verona reports part one data from phase II trial of DPI formulation of ensifentrine in COPD
Read More
Bristol-Myers Squibb presents lysophospholipid S1P1 receptor agonists
Read More
Arrowhead opens enrollment in phase I study of ARO-APOC3
Read More
Vyera Pharmaceuticals patents protozoal DHFR inhibitors
Read More
Single chain antibody against TDP-43 shows therapeutic potential in murine models of ALS/FTD
Read More
Vaccine targets generated by cell-free protein synthesis limit P. gingivalis-elicited oral bone loss
Read More
The Vanderbilt University discloses muscarinic M4 receptor antagonists
Read More
Rodin Therapeutics identifies HDAC inhibitors
Read More
Eli Lilly and Company synthesizes PDE1 inhibitors
Read More
Early trial data reported for anti-TIM-3 antibody LY-3321367 with anti-PD-L1 antibody LY-3300054
Read More
Funding to support exploration of TXA-127 for epidermolysis bullosa
Read More
Healx partners with Boston Children's Hospital to advance drug discovery in Barth syndrome
Read More
Lupus Therapeutics collaborates with Takeda on phase I trial of TAK-079 for SLE
Read More
OncBioMune initiates phase II study of Proscavax in localized prostate cancer
Read More
BirchBioMed initiates proof-of-concept study with FS-2 to reduce keloid scars
Read More
Apellis resumes enrollment in phase III geographic atrophy trials of APL-2
Read More
Axsome initiates phase III trial of AXS-07 for acute treatment of migraine
Read More